Physician profile
Jameson C Dear
NPI 1992025431
$6,300.71
in general payments reported to CMS, 2019-2025
18 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $187 · 2021: $2,376 · 2022: $414 · 2023: $1,778 · 2024: $854 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,129 · Travel and Lodging: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,129.29 |
| Travel and Lodging | $781.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,862.48 | 2019-2025 | Inspace, Mako, Alphavent |
| Depuy Synthes Sales INC. | $1,619.16 | 2019-2024 | Inhance, Va-Lcp |
| Musculoskeletal Transplant Foundation INC. | $396.96 | 2024 | |
| Mission Medical Distribution, LLC | $217.11 | 2023-2025 | |
| Embody, INC. | $197.74 | 2023 | |
| Horizon Therapeutics Plc | $167.89 | 2019 | |
| Globus Medical, INC. | $135.15 | 2019 | |
| Pylant Medical | $128.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $124.98 | 2021 | |
| Zimmer Biomet Holdings, INC. | $115.27 | 2020-2021 | |
| Abbott Laboratories | $81.51 | 2020-2021 | |
| Dilon Technologies, INC. | $59.87 | 2024 | Hemoblast Bellows |
| Medical Device Business Services, INC. | $44.34 | 2021 | |
| Bioventus LLC | $43.07 | 2019-2021 | |
| Medtronic, INC. | $32.73 | 2023-2025 | Intellis Adaptivestim |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $31.07 | 2021 | |
| Smith+Nephew, INC. | $28.34 | 2021 | |
| Acumed LLC | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jameson Dear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.